Compare ENLV & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | NNOX |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 126.0M |
| IPO Year | 2014 | 2019 |
| Metric | ENLV | NNOX |
|---|---|---|
| Price | $0.53 | $1.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.00 | $5.00 |
| AVG Volume (30 Days) | 343.3K | ★ 3.8M |
| Earning Date | 05-29-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $147.55 |
| Revenue Next Year | N/A | $81.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $0.73 |
| 52 Week High | $2.10 | $5.69 |
| Indicator | ENLV | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 26.36 | 41.28 |
| Support Level | N/A | $0.73 |
| Resistance Level | $1.25 | $1.88 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 3.53 | 50.25 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.